510(k) Report

510(k) · Cleared

Cleared

Vbeam Prima Laser System

K180593510(k) TraditionalCleared Jun 5, 201891-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Syneron-Candela · GEX Powered Laser Surgical Instrument

Cleared on Jun 5, 2018 as substantially equivalent to K050673 (Candela Corp., 2005) and 1 other predicate after a 91-day review. Its family tree reaches back 9 generations to 1991. 2 later devices descend from it.

Decided
Jun 5, 2018
Review
91 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
2

Its longest line of descent runs back 9 generations to K904627 (1991). 62 ancestors in all, the oldest K882160 (1988). 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor2004: 2 other ancestors2003: 5 other ancestors2000: 3 other ancestors1999: 4 other ancestors2002: 2 other ancestors2001: 2 other ancestors1998: 5 other ancestors1996: 5 other ancestors1995: 6 other ancestors1997: 5 other ancestors1994: 8 other ancestors1988: 1 other ancestor1993: 2 other ancestors1991: 2 other ancestors2019: 1 descendant cleared2023: 1 descendant clearedK904627 · Centauri Yag Laser Syst, Ear, Nose , Throat · Pfizer Laser Systems · 1991K960032 · Coherent Versapulse Aesthetic Surgical Lasers · Coherent Medical Group · 1996K972347 · Modified Coherent Versapulse Aesthetic Surgical Laser · Lumenis, Inc. · 1997K993671 · Candela Sclero Long Pulse Dye Laser · Candela Corp. · 2000×2: 2 generations cleared close together, K013748 (2002), K021180 (2002) K033461 · Candela Vbeam Pulse Dye Laser System · Candela Corp. · 2004×2: 2 generations cleared close together, K043251 (2005), K050673 (2005) 1990200020102020
  1. Root · 9 generations backK904627 Centauri Yag Laser Syst, Ear, Nose , ThroatPfizer Laser Systems · 1991
  2. 5 generations between
  3. 3 generations backK033461 Candela Vbeam Pulse Dye Laser SystemCandela Corp. · 2004
  4. 2 generations backK043251 Candela Family of Pulsed Dye Laser Systems, Models Vbeam, Cbeam…Candela Corp. · 2005
  5. 1 generation backK050673 Candela Family of Pulse Dye Laser SystemsCandela Corp. · 2005 · Recalled
  6. This deviceK180593 Vbeam Prima Laser SystemSyneron-Candela · 2018
  7. Descendant · cites it directly · 1 of its ownK183452 Vbeam Prima Laser SystemCandela Corp. · 2019
  8. Descendant · 2 generations on · 0 of its ownK230990 Candela Vbeam Family of Pulsed Dye Lasers (Vbeam Prima, Vbeam…Candela Corporation · 2023
Show all 9 generations
  1. Root · 9 generations backK904627 Centauri Yag Laser Syst, Ear, Nose , ThroatPfizer Laser Systems · 1991
  2. 8 generations backK960032 Coherent Versapulse Aesthetic Surgical LasersCoherent Medical Group · 1996
  3. 7 generations backK972347 Modified Coherent Versapulse Aesthetic Surgical LaserLumenis, Inc. · 1997
  4. 6 generations backK993671 Candela Sclero Long Pulse Dye LaserCandela Corp. · 2000
  5. 5 generations backK013748 Candela Sclero Long Pulse Laser (Aka Vbeam)Candela Corp. · 2002
  6. 4 generations backK021180 Candela Vbeam Pulsed Dye Laser SystemCandela Corp. · 2002
  7. 3 generations backK033461 Candela Vbeam Pulse Dye Laser SystemCandela Corp. · 2004
  8. 2 generations backK043251 Candela Family of Pulsed Dye Laser Systems, Models Vbeam, Cbeam…Candela Corp. · 2005
  9. 1 generation backK050673 Candela Family of Pulse Dye Laser SystemsCandela Corp. · 2005 · Recalled
  10. This deviceK180593 Vbeam Prima Laser SystemSyneron-Candela · 2018

Most influential descendants

Showing 2 of 2 · See all
  • K183452Vbeam Prima Laser SystemCandela Corp. · 2019 · cites it directly1descendant
  • K230990Candela Vbeam Family of Pulsed Dye Lasers (Vbeam Prima, Vbeam Perfecta)Candela Corporation · 2023 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K904627Centauri Yag Laser Syst, Ear, Nose , ThroatPfizer Laser Systems1991—
−8K960032Coherent Versapulse Aesthetic Surgical LasersCoherent Medical Group1996—
−7K972347Modified Coherent Versapulse Aesthetic Surgical LaserLumenis, Inc.1997—
−6K993671Candela Sclero Long Pulse Dye LaserCandela Corp.2000—
−5K013748Candela Sclero Long Pulse Laser (Aka Vbeam)Candela Corp.2002—
−4K021180Candela Vbeam Pulsed Dye Laser SystemCandela Corp.2002—
−3K033461Candela Vbeam Pulse Dye Laser SystemCandela Corp.2004—
−2K043251Candela Family of Pulsed Dye Laser Systems, Models Vbeam, Cbeam, SPTL-1BCandela Corp.2005—
−1K050673Candela Family of Pulse Dye Laser SystemsCandela Corp.20052
0 (this device)K180593Vbeam Prima Laser SystemSyneron-Candela2018—
+1K183452Vbeam Prima Laser SystemCandela Corp.2019—
+2K230990Candela Vbeam Family of Pulsed Dye Lasers (Vbeam Prima, Vbeam Perfecta)Candela Corporation2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198810
199120
199320
199480
199560
199650
199750
199850
199940
200030
200120
200220
200350
200420
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202310
FIG. 1 — Lineage of K180593, 1991–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K050673Candela Family of Pulse Dye Laser Systems
Summary page 4
…EX Device Classification: Class 2 Laser Classification: Class IV 5. PREDICATE DEVICE Candela Family of Pulsed Dye Laser Systems (K050673), primary predicate Cynosure Cynergy Multiplex Laser (K050779), additional predicate…
Candela Corp.20052
*K050779Cynergy Multiplex Laser
Summary page 4
…cation: Class IV 5. PREDICATE DEVICE Candela Family of Pulsed Dye Laser Systems (K050673), primary predicate Cynosure Cynergy Multiplex Laser (K050779), additional predicate Page 903 of 906 === P…
Cynosure, Inc.2005—

Also cleared against K050673: 2 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K183452Vbeam Prima Laser SystemCandela Corp.20191

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 5 companies; a new generation was cleared every 1.5 years on median.
  • 2 of the 62 ancestors have a recall of any class.
  • Of its descendants, K183452 (Candela Corp., 2019) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K050673.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

1,064nm: The Vbeam Prima Laser System is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lakes, leg veins, spider veins, and poikiloderma of civatte and treatment of benign cutaneous lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots), cafe au lait manules, seborrheic keratoses, nevi, chloasma…

Read the full statement (179 words)

1,064nm:

The Vbeam Prima Laser System is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lakes, leg veins, spider veins, and poikiloderma of civatte and treatment of benign cutaneous lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots), cafe au lait manules, seborrheic keratoses, nevi, chloasma, verrucea, skin tags, and keratoses. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles.

595 nm:

General Surgery: Photocoagulation of benign cutaneous vascular lesions and benign cutaneous lesions.

Dermatology/Plastic Surgery: For treatment of benign cutaneous vascular lesions, such as facial and leg telangiectasia, rosacea, port wine stains, hemangiomas, angioma, spider angioma, poikiloderma of civatte, and benign cutaneous lesions, such as warts, scars, striae, psoriasis and the treatment of wrinkles. Treatment of benign epidermal pigmented lesions. Treatment of inflammatory acne vulgaris.

Gynecology: Photocoagulation of benign cutaneous lesions and benign vascular lesions in gynecology.

Podiatry: Treatment of benign cutaneous lesions, such as warts.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K180593: Vbeam Prima Laser System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K180593

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026